1. An adverse immune-endocrine profile in patients with tuberculosis and type 2 diabetes. (December 2016) Authors: Fernández, R.; Díaz, A.; D'Attilio, L.; Bongiovanni, B.; Santucci, N.; Bertola, D.; Besedovsky, H.; del Rey, A.; Bay, M.L.; Bottasso, O. Journal: Tuberculosis Issue: Volume 101(2016) Page Start: 95 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Intranasal delivery of dexamethasone efficiently controls LPS‐induced murine neuroinflammation. (7th September 2017) Authors: Meneses, G.; Gevorkian, G.; Florentino, A.; Bautista, M. A.; Espinosa, A.; Acero, G.; Díaz, G.; Fleury, A.; Pérez Osorio, I. N.; del Rey, A.; Fragoso, G.; Sciutto, E.; Besedovsky, H. Journal: Clinical and experimental immunology Issue: Volume 190:Number 3(2017:Dec.) Page Start: 304 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OC-0608 Phase II trial of hypofractionated postoperative radiotherapy in prostate cancer: NCT02192788. (May 2022) Authors: Hervás, A.; Zapatero, A.; Carballo, A.M.; Barrado, M.; López-Campos, F.; Cano, C.; Martin de Vidales, C.; Rodríguez, A.; Eito, C.; Salinas, A.; Peleteiro, P.; Visus, I.; Rodríguez Melcón, I.; Vázquez, G.; Lazo, A.; Couñago, F.; Guerrero, L.; Otero, A.; Vasquez, W.A.; Samper, P. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S533 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗